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This 2003 report is an update on the epidemiological situation of tuberculosis in the WesternPacific Region and shows the progress of Directly Observed Treatment Short-course (DOTS)programmes. National Tuberculosis Programmes of 33 countries and areas (accounting
for a total population of 1.702 billion1) submitted data on cases notified during 2001 and the
treatment results of the cohort of patients registered during 2000. A standard form was used, based
on common definitions and variables.
In 2001, the 33 countries and areas notified 811 263 tuberculosis cases (all types) and 379 060
new smear-positive pulmonary cases. Notification rates were 48 per 100 000 and 22 per
100 000, respectively, showing no significant variation from recent years (Table 1, page viii). About
69% of the notified tuberculosis patients were aged 15–54, which is the most productive age group,
while the group aged 25–34 had the highest tuberculosis burden at 20% (all cases) (Table 6,
page 18).
Based on the estimated incidence for 2001, the case detection rate was 40% for all types and
41% for smear-positive cases (Table 1), well short of the World Health Organization (WHO) target
of 70%. Higher case detection rates were observed in DOTS areas (31% for all types and 37%
for new smear-positive cases) compared to non-DOTS areas (9% and 5%, respectively)
(Table 1). Further DOTS expansion should lead to an increase in case detection, especially of the
most contagious cases – those that are pulmonary smear-positive.
About 68% of the regional population had access to DOTS. The DOTS enrolment rate for new
smear-positive cases increased to 89%, from 78% in 2000 (Table 1). The treatment
success rate was 92.3% (Table 16, page 28) for pulmonary new smear-positive patients regis-
tered in 2000. Out of these, 89% were cured, exceeding the WHO target of 85%.
Among the seven countries with the highest burden of tuberculosis in the Region
(Cambodia, the People’s Republic of China, the Lao People’s Democratic Republic, Mongolia,
Papua New Guinea, the Philippines, and Viet Nam) Mongolia and Viet Nam passed WHO targets
of 70% DOTS case detection and 85% treatment success (for new smear-positive cases). Mongolia
passed the WHO targets during 2001, two years after full DOTS coverage was achieved in 1999.
The Philippines, although not yet reaching the target for detection (57% in 2001), managed almost
full DOTS coverage, five years after the introduction of DOTS.
In some countries, an increase was seen in the number of human immunodeficiency virus
(HIV) patients with tuberculosis. For instance, HIV prevalence among tuberculosis patients in-
creased from 6% in 2000 to 8.4% in 2002 in Cambodia (see profiles of high-burden countries in
Annex 1). The level of primary multidrug resistance in China is also a cause for concern.
Summary
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TABLE 1
Key indicators of tuberculosis control in the Western Pacific Region, 2001
All cases New S+ (%)All
cases (%)
New S+ (%)
Number
All
cases (%)
New S+
 (%)
All
cases (%)
New
S+
All
cases
New
 S+
All
cases
New
 S+ (%)
All
cases (%)
New
 S+ %
a
 70
19 338
 335
13 441
1 284 972
 20
 823
 237
 158
6961
127 335
 84
47 069
5403
 449
22 633
 76
 52
 126
2559
 13
 220
3808
 2
 20
4920
77 131
 0
 159
4108
 463
 1
 99
 10
 202
79 175
 15
1 702 484
Country
American Samoa
Australia
Brunei Darussalam
Cambodia
China
Cook Islands
Fiji
French Polynesia
Guam
Hong Kong, China
Japan
Kiribati
Republic of Korea
Lao PDR
Macao, China
Malaysia
N. Mariana Islands
Marshall Islands
Micronesia, FS
Mongolia
Nauru
New Caledonia
New Zealand
Niue
Palau
Papua New Guinea
Philippines
Pitcairn Islands
Samoa
Singapore
Solomon Islands
Tokelau
Tonga
Tuvalu
Vanuatu
Viet Nam
Wallis and Futuna
Western Pacific
Pop.
b
 3
 980
 216
19 170
485 221
 2
 183
 45
 63
7262
35 489
 189
37 268
2382
 465
14 830
 58
 56
 95
3526
 3
 64
 377
 0
3470
107 133
 22
1536
 292
 0
 11
 173
90 679
811 263
All
cases
Notification in DOTS and non-DOTS areas
v=p/h
19
19
0
0
4
0
0
0
0
17
28
0
80
0
0
0
0
0
0
0
0
41
26
0
0
0
0
0
22
0
0
0
0
13
0
5
*No. of estimated cases
u=o/g
13
32
0
0
8
0
0
0
0
24
39
0
114
6
0
0
0
0
0
0
0
35
70
0
0
0
0
0
42
0
0
0
0
31
0
9
Case detection rate
Pop. with access
to DOTS
t=n/h
0
14
114
41
29
67
59
67
78
55
28
201
0
27
94
68
66
76
17
72
106
0
11
0
9
57
50
21
67
0
53
60
84
37
No. of cases
in DOTS areas
%
s=m/g
0
32
116
24
25
30
66
56
47
103
40
267
0
13
125
55
91
128
90
70
71
0
22
0
29
46
41
40
75
0
33
71
63
31
No. of cases in
non-DOTS areas
r=n/d
0
43
100
100
89
100
100
100
100
77
50
100
0
100
100
100
100
100
100
100
100
0
31
0
100
100
100
49
100
0
100
82
100
89
Rate
q=m/b
0
49
100
100
75
100
100
100
100
81
50
100
0
68
100
100
100
100
100
100
100
0
24
0
100
100
100
49
100
0
100
70
100
78
**DOTS
enrolment rate
Number
p
2
129
0
0
24 286
0
0
0
0
428
5699
0
11 805
0
0
0
0
0
0
0
0
34
47
0
0
0
0
182
0
0
0
10
0
42 622
***DOTS case
detection rate
Rate
o
3
495
0
0
123 049
0
0
0
0
1355
17 680
0
37 268
764
0
0
0
0
0
0
0
64
288
0
0
0
0
787
0
0
0
52
0
181 805
Non-DOTS case
detection rate
n
0
99
95
14 361
188 480
2
73
24
47
1425
5709
64
0
1533
157
8309
19
15
8
1631
2
0
21
0
462
59 341
12
175
118
0
8
46
54 202
336 438
* 2001 update, WHO Geneva.
** DOTS enrolment rate is the proportion of all detected cases that are diagnosed and treated in DOTS areas.
*** DOTS detection rate is the proportion of total estimated cases that are diagnosed and treated under DOTS.
m
0
485
216
19 170
362 172
2
183
45
63
5907
17 809
189
0
1618
465
14 830
58
56
95
3526
3
0
89
0
3470
107 133
22
749
292
0
11
121
90 679
629 458
*Pop.
x 1000
l
100
54
100
100
68
100
100
97
100
100
46
100
0
80
100
100
100
100
70
100
100
0
100
100
13
97
100
100
90
0
98
65
100
68
k
70
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 20
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4323
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76
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 0
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 159
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79 016
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j=d/h
19
33
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41
33
67
59
67
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72
56
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80
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94
68
66
76
17
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41
37
0
9
57
50
42
67
0
53
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84
41
New S+
i=b/g
13
64
116
24
34
30
66
56
47
126
79
267
114
19
125
55
91
128
90
70
71
35
92
0
29
46
41
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75
0
33
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63
40
h
11
687
83
35 118
651 110
 3
 124
 36
 60
2587
20 227
 32
14 721
5755
 167
12 149
 29
 20
 48
2268
 2
 83
 184
 0
 7
5285
104 439
 24
 842
 176
 0
 15
 2
 77
64 535
 2
920 908
g
 23
1528
 185
78 564
1 447 947
 7
 276
 80
 133
5755
44 954
 71
32 787
12 789
 371
27 119
 64
 44
 106
5041
 4
 185
 409
 1
 17
11 771
232 266
 53
1874
 390
 0
 33
 3
 170
143 412
 5
2 048 439
f=d/b
67
23
44
75
44
100
40
53
75
26
32
34
32
64
34
56
33
27
8
46
67
53
18
0
13
55
55
23
40
0
73
0
32
60
47
e
3
1
28
107
17
10
9
10
30
27
9
76
25
28
35
37
25
29
6
64
16
15
2
0
9
77
8
9
25
0
8
28
68
22.3
d
 2
 228
 95
14 361
212 766
 2
 73
 24
 47
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11 408
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11 805
1533
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 19
 15
 8
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 2
 34
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 0
 462
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 357
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 0
 8
 56
54 202
379 060
c
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5
65
143
38
10
22
19
40
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28
225
79
44
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66
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24
29
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0
71
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0
11
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2This report is based on case notification and treatment outcome data supplied by NationalTuberculosis Programmes (NTPs) to the World Health Organization (WHO) for 2001,using a standard data collection form, with common definitions and variables.
1.1 Notification of tuberculosis cases by type of
tuberculosis
In 2001, 33 out of 37 countries and areas of the Western Pacific Region with a combined
population of 1.702 billion submitted tuberculosis data for 2001. Together, they notified 811 263
tuberculosis cases (all types2 ) (47.7 per 100 000 population), 379 060 new smear-positive
pulmonary cases (22.3 per 100 000), 307 228 new pulmonary smear-negatives, 32 852
extrapulmonary cases and 36 178 relapses (Tables 1, page viii, and 5, page 17).
The four non-reporting countries – Palau, the Pitcairn Islands, Tuvalu, and Wallis and Fortuna
— have a combined population of only 45 000.
All types
Among the 811 263 tuberculosis cases (all types) in the Region (Figure 1), the People’s Republic
of China (China) notified 485 221 cases (61%), the Philippines 107 133 (13%), Viet Nam 90 679
(11%), the Republic of Korea 37 268 (5%), Japan 35 489 (4%) and Cambodia 19 170 (2%)
(Table 1, Page viii). The 27 other countries together notified 36 303 cases (4%). Eight countries
reported a notification rate (all types) greater than 100, and 13 countries reported a rate lower than
30 (Table 1).
Pulmonary new smear-positive cases
Out of the 379 060 new smear-positive cases in the Region, China notified 212 766 cases (56%),
the Philippines 59 341 (16%), Viet Nam 54 202 (14%), Cambodia 14 361 (4%), Korea 11 805
(3%) and Japan 11 408 (3%). The 27 other countries together notified 15 177 cases (4%)
(Tables 1 and 5).
The regional average notification rate for new smear-positive cases was 22.3 per 100 000
population, with the highest rate in Cambodia (107). The rate ranged between 25 and 100 in
15 countries: 77 in the Philippines; 76 in Kiribati; 68 in Viet Nam; 64 in Mongolia; 37 in
Review of
tuberculosis
epidemiology
2 In 2001, 956 re-treatment after failure cases and 23 667 other re-treatment cases were not included in the
notification.
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Malaysia; 35 in Macao, China; 30 in Guam; 29 in the Marshall Islands; 28 in Brunei Darussalam,
the Lao People’s Democratic Republic and Vanuatu; 27 in Hong Kong, China; and 25 in the
Republic of Korea, the Northern Mariana Islands and Solomon Islands. China notified 17 new
smear-positive cases per 100 000 population. Four industrialized countries (Japan, Australia, New
Zealand and Singapore) and 12 Pacific island countries had lower rates (Table 1, page viii).
The proportion of new smear-positive cases out of all notified cases was 47% for the Region.
China’s rate was 44%. Thirteen countries, including five of the seven with the highest burden
(Cambodia, the Lao People’s Democratic Republic, Mongolia, the Philippines and Viet Nam)
notified proportions higher than 50% (Table 1).
Directly Observed Treatment Short-course (DOTS) areas reported 53% of new smear-posi-
tive cases (336 438 new smear-positives out of 629 458 all cases) compared to only 23% in non-
DOTS areas (42 622 new smear-positives out of 181 805 all cases) (Table 1 and Figure 2).
Extrapulmonary tuberculosis cases were not reported in China. The 32 852 extrapulmonary
cases reported in the 32 other countries represented 4% of all notified cases (Table 5, page 17).
FIGURE 1
Distribution of notified tuberculosis all types by country, Western Pacific Region, 2001
Total: 811 263 tuberculosis cases, all types
FIGURE 2
Notified cases by type of tuberculosis in DOTS and non-DOTS areas, Western Pacific Region, 2001
China
61%
Philippines
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Viet Nam
11%
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5%
Japan
4%
Cambodia
2%
Others
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New pulmonary smear-positive
New pulmonary smear-negative
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1.2 Notification of new smear-positive pulmonary
cases by age and gender
About 69% of new smear-positive cases are aged between 15 and 54, the most productive age
group, with the highest concentration (20%) in the group aged 25–34 (Table 6, page 18).
On average, two male tuberculosis smear-positive cases are notified for every female one (a
sex ratio of 2:1) in the Region (Table 7, page 19). By age group, the sex ratio was 0.8:1 in the
0–14 year old group (more females than males), 1.3:1 in the 15–24 year old group and then
increased in the older age groups (Figure 3 below).
FIGURE 3
Notification of new smear-positive cases by age and gender, DOTS and non-DOTS areas,
Western Pacific Region, 2001
1.3 Case detection rate
The case detection rate (see Annex 2 for definition) was 40% for all tuberculosis cases and 41%
for new smear-positive cases (Table 1, page viii). In other words, in the Region, the 811 263
notified cases (all types) represented 40% of the 2 048 439 estimated cases (all types) and the
379 060 notified new smear-positive cases represented 41% of the 920 908 estimated new smear-
positive cases. Figures of estimated cases (annual incidence) are based on the 2001 update of
estimated cases from WHO, Geneva, with projections based on Global Burden of Tuberculosis,3
1999.
1.4 Trends in notification
Trends in notification for all types and new smear-positive cases are given by country in Tables 8
to 11 in Part II (pages 20–23). Overall notification rates both for all types and new smear-positive
cases have not changed significantly in recent years (Figure 4 opposite). Trends in notification
3 Dye C, Scheele S, Dalin P et al. Global Burden of Tuberculosis. Estimated Incidence, Prevalence, and Mortality
by Country. JAMA 282: 677–686, 1999.
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may reflect variations in performance in case finding as well as changes in the burden of the
disease. They may thus be misleading, with their interpretation biased by variations in the reporting
system and/or the use of different denominators (estimates of population). Moreover, trends in case
detection rates will also be affected by changes in the estimated incidence.
FIGURE 4
Trend in notification rates of tuberculosis, Western Pacific Region, 1993–2001
For individual countries, notification increased slightly in China and Viet Nam after 1998, but
decreased in Cambodia and the Philippines (Table 2, below, and Figure 5, overleaf).
TABLE 2
Trend in case notification (rates per 100 000) in Cambodia, China, the Philippines and Viet Nam,
Western Pacific Region, 1995–2001
1995 1996 1997 1998 1999 2000 2001
Cambodia
All 146 145 149 158 175 157 143
New S + 111 117 121 129 143 123 107
China
All 29 38 34 36 36 37 38
New S + 11 14 15 17 17 17 17
Philippines
All 347 399 295 222 198 168 139
New S + 140 125 118 99 100 88 77
Viet Nam
All 76 99 111 112 112 117 115
New S + 51 65 70 70 68 69 68
Western Pacific Region
All 48 58 51 51 49 49 48
New S + 20 22 23 24 24 23 22
1993 1994 1995 1996 1997 1998 1999 2000 2001
10
20
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All types New smear-positive
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FIGURE 5
Trend in notification of smear-positive cases (rate per 100 000) in Cambodia, China, the
Philippines and Viet Nam, Western Pacific Region, 1995–2001
1.5 Prevalence of HIV infection among
tuberculosis patients
Tuberculosis patients have been included in the surveillance sentinel groups for human
immunodeficiency virus (HIV) infection prevalence surveys in Cambodia and Viet Nam. HIV
sero-prevalence in newly detected tuberculosis cases increased from 6% in 2000 to 8.4% in
Cambodia (2002 survey). HIV sero-prevalence in 2001 was 4.9% in Malaysia; 3% in Fiji; 1.2%
in New Zealand; 1% in Papua New Guinea and the Northern Mariana Islands; 0.5% in Hong
Kong, China and Macao, China; and 0.3% in Singapore.
1.6 Primary multidrug resistance
Primary multidrug resistance (combined resistance to at least rifampicin and isoniazide) was
found in China in 2000, ranging from 2.9% to 5.3% of newly detected cases in three provinces
(Guangdong 5.3%, Zhejiang 4.3% and Shandong 2.9%) (see profiles of high-burden countries
in Annex 1).
1995 1996 1997 1998 1999 2000 2001
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7Among the 33 countries and areas of the Region that reported in 2001, 30 had at least partof their population served by DOTS units, compared to 18 in 1998. Twenty-nine countrieshad a tuberculosis manual, 20 had a special budget for tuberculosis control, 26 had a
centralized system for the procurement and distribution of tuberculosis drugs, 15 had a system to
prevent the sale of rifampicin to the general public, 22 had a reference laboratory and 19 had a
mechanism for collecting notification of tuberculosis cases from private practitioners.
2.1 Population with access to DOTS
The population in the Region with access to DOTS increased slightly from 67% in 2000 to 68%
in 2001 (Table 1, page viii). DOTS was applied in 52% of operational health units (2528 out of
4841) in the Region; for China, the percentage was 49% (1560 out of 3164 health units).
Twenty-two countries achieved 97% DOTS coverage or above (American Samoa; Brunei
Darussalam; Cambodia; Cook Islands; Fiji; French Polynesia; Guam; Hong Kong, China; Kiribati;
Macao, China; Malaysia; the Marshall Islands; Mongolia; Nauru; New Zealand; Niue; the North-
ern Mariana Islands; the Philippines; Samoa; Singapore; Tonga; and Viet Nam). The population
with access to DOTS was 90% in Solomon Islands, 80% in the Lao Peoples’ Democratic Republic,
70% in the Federated States of Micronesia, 68% in China, 65% in Vanuatu, 54% in Australia, 46%
in Japan and 13% in Papua New Guinea. Among the countries that made the biggest progress
compared to the previous year were Vanuatu (50% to 65%), Japan (36% to 46%), the Lao
People’s Democratic Republic (70% to 80%), the Philippines (90% to 97%) and Papua New
Guinea (8% to 13%) (Table 1).
2.2 DOTS enrolment
In 2001, 78% of all cases and 89% of new smear-positive cases in the Region were diagnosed
and treated under DOTS (Table 1). This marks a rapid improvement since 1999, when the figures
were 69% for all cases and 78% for new smear-positive cases. The increase was particularly
marked in the Philippines (from 28% in 1999 to 100% in 2001) and Japan (from 37% in 1999 to
50% in 2001).
Review of DOTS
implementation and
treatment results
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FIGURE 6
Trends in population with access to DOTS and DOTS enrolment rate (all cases) in the Western
Pacific Region, 1998–2001
2.3 Treatment results of new smear-positive cases
In DOTS areas, the treatment success rate was 92.3% for the cohort of 320 046 new
pulmonary smear-positive cases treated in 2000 (they represented 83% of the 385 434 cases
notified that year) (Table 16, page 28). The cure rate among reported cases was 88.9%,
completed treatment 3.5%, defaulted 2%, treatment failures 1.1%, died 1.9% and transferred out
1.4%. The percentage of cases not evaluated was 1.3%. In China, 89% of new smear-positive
cases were registered for treatment results (191 280 out of 213 766 notified in 2000) and the
treatment success rate was 95%.
In non-DOTS areas, the treatment success rate was 69.8% out of 38 139 cases (which in
turn comprise 66% of the 57 741 cases notified in 2000) (Table 17, page 29). In China, 97% of the
22 486 cases notified in 2000 were evaluated and the treatment success was 81.3%.
2.4 Treatment results of re-treatment cases
In DOTS areas, 54 043 re-treatment cases registered in 2000 were evaluated (including
relapses, failures and returns after treatment interruption). The treatment success rate for
these was 86.6%. The cure rate was 83.5%, completed treatment 3%, defaulted 1.3%,
treatment failures 2%, died 2.2%, transferred out 0.9% and 7.2% of the cases were not
evaluated (Table 18, page 30).
In non-DOTS areas, the treatment success rate for re-treatment cases was 31.3% (Table 19,
page 31). Out of 728 re-treated cases registered in 2000, 57% were not evaluated; therefore, the
cure rate was only 23%, completed treatment 8.4%, defaulted 2.2%, treatment failures 4.1%, died
2.1% and transferred out 3.6%.
In DOTS areas,
the treatment
success rate was
92.3% for the
cohort of
320 046 new
pulmonary smear-
positive cases
treated in 2000.
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FIGURE 7
Treatment success in DOTS and non-DOTS areas, 2000 cohort
DOTS Non-DOTS
0
25
50
75
100
Not evaluated Others Treatment success
DOTS Non-DOTS
0
25
50
75
100
New smear-positive cases Re-treatment cases%%
10
Seven countries in the Region – Cambodia, China, the Lao People’s Democratic Republic,Mongolia, Papua New Guinea, the Philippines and Viet Nam – have been identified ashigh-burden countries for tuberculosis.
In 2001, these seven countries accounted for 86% of the Region’s population and 94% of all
estimated incident cases (or more than 1.9 million new cases by year). They notified 88% of all
cases (711 581 out of 811 263 cases) and 91% of the smear-positive cases in the Region (344 296
out of 379 060 cases). The average case detection was 33% for all types and 40% for the new
smear-positive cases. DOTS expansion made the best progress in this group of countries. In
2001, 71% of the population of these countries had access to DOTS and the DOTS enrolment rate
for pulmonary new smear-positive cases was 83%. Treatment success exceeded 85% in five of
these countries, including China. Mongolia and Viet Nam have reached the targets of 70% case
detection and 85% treatment success (for new smear-positive cases). In 2001, Mongolia passed
the WHO targets for the first time, two years after achieving full DOTS coverage in 1999. Viet Nam
has been maintaining high case detection and treatment success for several years. Cambodia,
China and the Philippines have all exceeded the 85% treatment success target.
3.1 Tuberculosis control policies and DOTS
components in high-burden countries
All high-burden countries are using WHO-recommended national tuberculosis guidelines
and have central procurement and distribution systems for tuberculosis drugs as well as a
national reference laboratory. Five countries allot a separate budget for tuberculosis control.
DOTS is implemented in all public hospitals in Cambodia, Mongolia, the Philippines and Viet
Nam, and in 80% of hospitals in the Lao People’s Democratic Republic, 58% in China and 13%
in Papua New Guinea. Most of the countries use sputum smear microscopy for diagnosis, the
exception being Papua New Guinea, where it is used in some units only. Directly observed
treatment (DOT) is applied in all public health units within DOTS areas. Treatment and smear
microscopy examinations are free of charge for the patients in six countries, while China has a
patient fee system. Reporting of treatment results is based on cohort analysis in all units in
Cambodia, the Lao People’s Democratic Republic, Mongolia, Papua New Guinea and Viet
Nam, and in some units in China and the Philippines. Screening and treatment of contact children
is carried out in some units only.
Tuberculosis
control in high-
burden countries
CHAPTER 3
In 2001, the seven
high-burden
countries
accounted for
86% of the
Region’s
population and
94% of all
estimated
incident cases (or
more than
1.9 million new
cases by year).
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3.2 Notification in high-burden countries
In 2001, the notification rate for all cases exceeded 100 per 100 000 population in four of the
seven high-burden countries: 143 in Cambodia, 139 in the Philippines, 138 in Mongolia and
115 in Viet Nam. These seven notified a higher proportion of pulmonary smear-positive cases
(48% of all cases) than other areas of the Region, where they accounted for 35% of all cases. The
estimated incidence4 of smear-positive cases was 59 per 100 000 in the seven high-burden
countries, compared to 22 per 100 000 in the others. However, at 40%, the case detection rate for
smear-positives was lower in the high-burden countries compared to 66% in the other countries.
The case detection rate was 34% in China, where more than 70% of the estimated cases of the
Region reside; therefore DOTS expansion in China is a pre-condition for reaching the WHO target
of 70% case finding in the Region.
The notification rate of new smear-positive cases increased between the years 1995 and 2001
in Mongolia. It also rose slightly in China,  the Lao People’s Democratic Republic and Viet Nam.
Cambodia and the Philippines have seen a decrease since 1999. Fluctuations in the Papua New
Guinea results are mostly due to significant variations in the reporting system; only the cases
registered in DOTS areas were reported in 2001 (Figure 8, below).
FIGURE 8
Trend in notification rate (per 100 000) of new smear-positive cases, high tuberculosis burden
countries in the Western Pacific Region, 1995–2001
4 Based on the 2001 update of estimated cases from WHO, Geneva.
3.3 DOTS implementation in high-burden countries
DOTS has made faster progress in high-burden countries than in others. By the end of 2001, 71%
of their population had access to DOTS, compared to 47% in other countries. Nearly all of the
populations of Cambodia, Mongolia and Viet Nam can access DOTS. DOTS coverage has also
risen to 97% in the Philippines (from 75% in 2000), 80% in the Lao People’s Democratic Republic
(from 70% in 2000), and 13% in Papua New Guinea (from 8% in 2000). The proportion of
population with access to DOTS in China remained the same as the previous year at 68%
(Table 3, overleaf).
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TABLE 3
DOTS in high-burden countries, Western Pacific Region, 1998–2001 (%)
Country 1998 2001 1998* 2001** 1998 2001 1998 2001
Cambodia 100 100 54 41 100 100 54 41
China 64 68 33 33 89 89 30 29
Lao PDR 71 80 39 27 99 100 39 27
Mongolia 97 100 57 72 89 100 51 72
Papua New Guinea 9 13 41 9 20 100 8 9
Philippines 17 97 70 57 14 100 10 57
Viet Nam 96 100 83 84 97 100 81 84
High-burden countries 63 71 43 40 76 93 32 37
Other countries 24 47 66 66 33 47 22 31
Western Pacific Region 58 68 44 41 72 89 32 37
Population with
access to DOTS
DOTS
enrolment
new S+
Case detection
rate*
new S+
DOTS case
detection rate*
new S+
* Case detection rates and DOTS case detection rates have been made available since the publication of estimated cases in Global
Burden of Tuberculosis, 1999.
** Updated estimates are given for 2001.
FIGURE 9
Comparison of population with access to DOTS in high-burden countries, Western Pacific
Region, 1998 and 2001
The DOTS enrolment rate is also much greater in the high-burden countries. About 93% of the
new pulmonary smear-positive cases were detected and treated by DOTS in high-burden
countries compared to 47% in other countries (the DOTS enrolment rate was 83% for all types in
high-burden countries compared to 42% in other countries).
The highest increase for population with access to DOTS was in the Philippines – from 17% in
1998 to 97% in 2001. In China, an increase of 4 percentage points since 1998 translates as
70 million more people with access to DOTS (Figure 9, below).
About 93% of the
new pulmonary
smear-positive
cases were
detected and
treated by DOTS
in high-burden
countries
 compared to 47%
in other countries.
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TABLE 4
Treatment outcomes of new smear-positive cases in seven high-burden countries, cohort 2000 in DOTS areas, Western Pacific
Region
Registered Not evaluated Cured Completed Defaulted Failed Died Transferred Treatment
Country number  (% ) (%) treatment (%) (%) (%) (%) out (%) success (%)*
Cambodia  14 775 0.0 87.8 3.5 3.9 0.3 3.6 0.8 91.4
China 19 1280 1.8 94.6 0.0 0.8 1.0 1.0 0.9 94.6
Lao PDR     1392 0.0 72.8 8.7 8.5 0.4 6.8 2.8 81.5
Mongolia     1389 0.1 83.2 3.7 4.2 3.3 2.7 2.8 86.8
Papua New Guinea      422 4.7 38.6 24.2 25.6 0.5 2.4 4.0 62.8
Philippines  50 196 0.1 72.6 15.2 5.8 1.2 2.3 2.8 87.8
Viet Nam  53 169 0.1 89.9 2.2 1.8 1.0 3.1 1.9 92.1
High-burden countries 312 623 1.1 89.7 3.1 2.0 1.0 1.7 1.4 92.8
Other countries     7396 8.8 52.6 20.2 2.7 5.4 8.3 2.1 72.8
Western Pacific Region 320 019 1.3 88.9 3.5 2.0 1.1 1.9 1.4 92.3
*Treatment success is the sum of cured and completed treatment.
5 Among the cohort of new smear-positive pulmonary patients registered for a treatment outcome in 2000.
3.4 Treatment results in high-burden countries
Better treatment outcomes were observed in the high-burden countries with the greatest DOTS
enrolment. Treatment success in DOTS areas was 93% in high-burden countries (new smear-
positive cases registered in 2000), compared to 73% in other countries. The proportion of patients
not evaluated5  was only 1% in high-burden countries, compared to 9% in other countries
(Table 4, below).
The cure rate was 90% in high-burden countries (53% in others), died 1.7% (8.3% in others),
treatment failure 1% (5.4%) and defaulted 2% (2.7%) (Table 4). Patients treated under DOTS
benefited from better management and follow-up (including sputum examinations at the end of
treatment to confirm that the patient had been “cured”).
By country, the treatment success for pulmonary new smear-positive cases exceeded 85%
in five countries, while it was 82% in the Lao People’s Democratic Republic (compared to 62%
in 1997) and 63% in Papua New Guinea (Table 4). The Philippines’ figures improved from 83%
in 1997 to 88% in 2001. Cambodia, China and Viet Nam have also maintained high treatment
success rates since 1997.
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TABLE 5
Notification of tuberculosis cases by type, Western Pacific Region, 2001
% out of % out of new % of all S+ out % out of % out of
Country New  the total  pulmonary Relapse  of all pulmonary the total the total
American Samoa 2 67 100 0 100 0 0 1 33 3
Australia 228 23 46 29 52 236 24 372 38 980
Brunei Darussalam 95 53 9 58 74 34 27 13 216
Cambodia 14 361 75 86 721 90 1658 9 2430 13 19 170
China 212 766 44 49 19 729 53 203 252 42 0 485 221
Cook Islands 2 100 100 0 100 0 0 0 0 2
Fiji 73 40 54 1 54 62 34 47 26 183
French Polynesia 24 53 80 0 80 6 13 8 18 45
Guam 47 75 94 1 96 2 3 3 5 63
Hong Kong, China 1853 26 34 233 39 3294 45 824 11 7262
Japan 11 408 32 41 1248 46 14 836 42 6621 19 35 489
Kiribati 64 34 68 6 74 24 13 74 39 189
Republic of Korea 11 805 32 40 3145 50 14 912 40 3797 10 37 268
Lao PDR 1533 64 71 85 75 533 22 231 10 2382
Macao, China 157 34 40 26 47 206 44 48 10 465
Malaysia 8309 56 62 0 62 5139 35 1382 9 14 830
N. Mariana Islands 19 33 38 0 38 31 53 8 58
Marshall Islands 15 27 39 0 39 23 41 14 25 56
Micronesia, FS 8 8 26 0 26 23 24 21 22 95
Mongolia 1631 46 65 113 70 757 21 1025 29 3526
Nauru 2 67 67 0 67 1 33 0 0 3
New Caledonia 34 53 68 2 72 14 22 14 22 64
New Zealand 68 18 48 11 56 63 17 108 29 377
Niue 0 0 0 0 0
Palau 0
Papua New Guinea 462 13 23 29 25 1496 43 1483 43 3470
Philippines 59 341 55 55 5379 60 42 413 40 0 0 107 133
Pitcairn Islands 0
Samoa 12 55 75 1 81 3 14 6 27 22
Singapore 357 23 28 62 33 861 56 196 13 1536
Solomon Islands 118 40 50 0 50 118 40 54 18 292
Tokelau 0 0 0 0 0
Tonga 8 73 80 1 90 1 9 1 9 11
Tuvalu 0
Vanuatu 56 32 40 0 40 84 49 33 19 173
Viet Nam 54 202 60 71 5347 78 17 106 19 14 024 15 90 679
Wallis and Futuna 0
Total 379 060 47 52 36 178 57 307 228 38 32 852 4 811  263
All
types
Extra-
pulmonary
Sputum negativeSputum positive
Pulmonary
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TABLE 6
Age and sex distribution of new sputum smear-positive (S+) cases in DOTS and non-DOTS areas, Western Pacific Region,* 2001
Country 0-14 15-24 25-34 35-44 45-54 55-64 >=65 Total 0-14 15-24 25-34 35-44 45-54 55-64 >=65 Total 0-14 15-24 25-34 35-44 45-54 55-64 >=65 Total
American Samoa 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 2 0 0 0 1 0 1 0 2
Australia 1 23 20 18 18 13 35 128 1 21 27 16 7 8 20 100 2 44 47 34 25 21 55 228
Brunei Darussalam 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cambodia 29 600 1302 1601 1406 1403 1037 7378 25 455 1033 1526 1687 1428 829 6983 54 1055 2335 3127 3093 2831 1866 14 361
China 1213 19 121 28 520 25 544 25 759 20 789 22 799 143 745 1405 14 500 17 446 12 041 9963 7175 6491 69 021 2618 33 621 45 966 37 585 35 722 27 964 29 290 212 766
Cook Islands 0 0 0 0 0 0 2 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 2
Fiji 0 6 8 11 7 4 2 38 0 7 5 7 1 2 2 24 0 13 13 18 8 6 4 62
French Polynesia 2 5 1 2 4 4 5 23 3 7 1 1 3 4 3 22 5 12 2 3 7 8 8 45
Guam 0 1 4 10 9 3 6 33 0 2 3 3 4 2 1 15 0 3 7 13 13 5 7 48
Hong Kong, China 6 79 100 162 196 200 518 1261 13 88 119 83 58 34 197 592 19 167 219 245 254 234 715 1853
Japan 3 220 576 632 1319 1513 3840 8103 5 175 437 228 250 330 1880 3305 8 395 1013 860 1569 1843 5720 11408
Kiribati 4 10 7 3 3 5 3 35 4 7 7 3 3 4 1 29 8 17 14 6 6 9 4 64
Republic of Korea 23 942 1415 1419 1293 1103 1361 7556 45 839 890 489 326 390 1270 4249 68 1781 2305 1908 1619 1493 2631 11805
Lao PDR 8 79 136 172 215 182 161 953 6 51 97 119 134 102 66 575 14 130 233 291 349 284 227 1528
Macao, China 0 9 17 26 25 11 23 111 1 5 7 11 10 1 11 46 1 14 24 37 35 12 34 157
Malaysia 48 713 1198 1221 1011 934 738 5863 36 510 506 445 374 353 222 2446 84 1223 1704 1666 1385 1287 960 8309
N. Mariana Islands 0 1 3 0 4 2 0 10 0 5 4 0 0 0 0 9 0 6 7 0 4 2 0 19
Marshall Islands 3 8 4 2 4 2 0 23 5 6 4 7 8 2 1 33 8 14 8 9 12 4 1 56
Micronesia, FS 0 2 0 0 2 1 0 5 1 0 1 0 0 1 0 3 1 2 1 0 2 2 0 8
Mongolia 13 236 268 179 86 45 36 863 25 253 260 125 48 28 29 768 38 489 528 304 134 73 65 1631
Nauru 0 0 1 1 0 0 0 2 0 0 0 0 1 0 0 1 0 0 1 1 1 0 0 3
New Caledonia 0 1 7 1 5 6 6 26 1 1 2 1 0 0 3 8 1 2 9 2 5 6 9 34
New Zealand 1 7 2 7 4 2 12 35 3 9 14 3 1 3 5 38 4 16 16 10 5 5 17 73
Niue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Palau 0 0 0 0 0 0 0
Papua New Guinea 4 101 72 29 26 9 4 245 7 91 64 32 17 5 1 217 11 192 136 61 43 14 5 462
Philippines 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Pitcairn Islands 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Samoa 1 3 1 1 0 0 1 7 0 1 1 2 1 1 1 7 1 4 2 3 1 1 2 14
Singapore 1 6 19 39 70 66 76 277 1 5 7 19 15 9 24 80 2 11 26 58 85 75 100 357
Solomon Islands 31 25 24 20 19 21 8 148 31 31 29 15 24 7 3 140 62 56 53 35 43 28 11 288
Tokelau 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Tonga 0 0 1 0 0 2 1 4 0 0 2 1 1 0 0 4 0 0 3 1 1 2 1 8
Tuvalu 0 0 0 0 0 0 0
Vanuatu 0 8 5 4 8 4 0 29 1 9 4 4 3 5 0 26 1 17 9 8 11 9 0 55
Viet Nam 39 2756 6319 8457 7054 5205 7643 37 473 48 1390 2357 2656 2574 2530 5174 16 729 87 4146 8676 11 113 9628 7735 12 817 54 202
Wallis and Futuna 0 0 0 0 0 0 0
Western Pacific Region 1430 24 962 40 030 39 561 38 547 31 529 38 317 214 376 1667 18 468 23 327 17 838 15 513 12 425 16 234 105 472 3097 43 430 63 357 57 399 54 060 43 954 54 551 319 848
% 1 12 19 18 18 15 18 100.00 2 18 22 17 15 12 15 100.00 1 14 20 18 17 14 17 100.00
New S+ males New S+ females New S+ males and females
*Breakdown of cases by age and sex was not available for the Philippines.
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TABLE 7
Notification rate per 100 000 of new sputum smear-positive cases by age and sex
in DOTS and non-DOTS areas, Western Pacific Region, 2001
Western Pacific Region* Population Number of new S+ cases Rates per 100 000
0–14 208 696 710 1430 0.7
15–24 130 963 661 24 962 19.1
25–34 154 190 079 40 030 26.0
35–44 120 294 576 39 561 32.9
45–54 95 722 295 38 547 40.3
55–64 59 709 423 31 529 52.8
>=65 54 667 272 38 317 70.1
Total 824 244 016 214 376 26.0
0–14 189 488 306 1667 0.9
15–24 122 365 550 18 468 15.1
25–34 147 455 225 23 327 15.8
35–44 114 644 560 17 838 15.6
45–54 91 278 229 15 513 17.0
55–64 57 526 734 12 425 21.6
>=65 67 348 448 16 234 24.1
Total 790 107 052 105 472 13.3
0–14 398 185 016 3097 0.8
15–24 253 329 211 43 430 17.1
25–34 301 645 304 63 357 21.0
35–44 234 939 136 57 399 24.4
45–54 187 000 524 54 060 28.9
55–64 117 236 157 43 954 37.5
>=65 122 015 720 54 551 44.7
Total 1 614 351 068 319 848 19.8
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TABLE 8
Trend in notified tuberculosis cases (all types) in DOTS and non-DOTS areas
Year
1977 7 1251 257 95 67 7191 89 245 97 10 264 8 1075 608 7 2212 107 108 36 2760 355 62 150 222 855
1978 8 1292 230 183 78 64 6623 80 629 40 10 441 6 1107 595 14 2446 118 587 59 2964 411 89 131 68 650 294 647
1979 2 1542 216 30 205 81 71 7903 76 455 94 81 910 442 11 094 4 1123 542 9 2232 108 813 58 2800 452 71 7 184 11 821 308 161
1980 2 1457 196 37 210 73 55 8065 70 916 146 89 803 1101 11 168 6 1160 108 474 17 2525 112 307 59 2710 266 64 33 178 43 062 346 198
1981 6 1386 285 10 180 58 41 7729 65 867 187 98 532 585 10 970 26 7 1094 128 448 10 2418 116 821 49 2425 313 49 18 92 43 506 353 240
1982 6 1270 245 8158 98 654 19 163 48 49 7527 63 940 193 11 894 75 12 67 1325 107 437 17 2742 104 715 43 2179 324 0 45 12 173 51 206 355 645
1983 8 1219 276 7572 117 557 29 185 66 48 7301 62 021 127 91 572 455 11 634 74 15 73 1514 161 415 14 2954 106 300 41 2065 302 50 23 171 43 185 457 427
1984 12 1299 256 10 241 151 564 20 165 73 54 7843 61 521 111 85 669 671 10 577 58 12 75 1652 144 402 20 3505 151 863 37 2143 337 0 54 9 188 43 875 534 450
1985 5 1088 238 10 145 226 899 36 230 75 37 7545 58 567 103 87 169 571 10 569 64 15 66 2994 104 359 26 3678 151 028 1952 377 2 49 32 124 46 941 611 088
1986 8 906 212 10 325 265 095 17 199 79 49 7432 56 690 129 88 789 420 10 735 16 37 60 2819 98 320 13 2877 153 129 1760 292 35 27 131 47 557 650 256
1987 9 907 189 9106 313 604 16 173 63 34 7269 56 496 110 87 419 389 11 068 49 32 97 2433 74 296 38 3235 163 740 29 1616 334 9 24 22 90 55 505 714 475
1988 13 954 126 10 691 362 114 15 162 64 41 7021 54 357 208 74 460 320 10 944 27 11 77 2538 111 295 17 4261 183 113 29 1666 372 1 14 24 118 52 463 766 627
1989 5 952 128 7906 367 799 1 218 58 75 6704 53 112 121 70 012 274 10 686 28 7 68 2233 110 303 3 3396 217 272 37 1617 488 35 25 144 52 270 796 087
1990 15 1016 143 6501 375 481 1 252 59 40 6510 51 821 68 63 904 343 10 873 1659 130 348 2497 317 008 44 1591 382 1 23 23 140 47 536 888 409
1991 2 950 10 903 376 246 210 49 6283 50 612 57 864 1951 329 11 059 1611 140 335 6 3401 207 371 309 19 16 234 54 509 784 409
1992 1011 16 148 12 240 83 6534 48 956 100 48 070 994 294 11 420 67 52 111 1516 140 317 2 2540 236 172 26 1512 364 1 23 30 147 56 594 4 433 480
1993 4 991 160 13 270 344 218 6 82 70 6537 47 437 46 999 1905 318 12 075 61 151 1418 149 274 1 25 5516 174 189 49 1722 367 32 28 114 52 994 711 162
1994 15 112 363 804 4 225 89 94 6319 44 590 253 38 155 1135 349 11 708 46 171 1730 4 132 352 2 41 5335 180 044 45 1677 332 0 23 19 152 51 763 11 723 716
1995 6 1073 0 14 599 357 829 1 203 0 0 6212 43 078 0 33 196 1307 354 11 778 40 0 0 3010 0 0 307 1 19 8041 235 496 0 51 1889 352 1 20 36 79 55 739 4 774 721
1996 0 1073 0 14 857 469 358 0 200 86 0 6501 42 122 327 31 134 1440 455 12 902 0 56 94 3010 0 205 323 2 5 5087 276 295 0 37 1889 289 1 22 0 0 74 711 0 942 481
1997 6 1145 0 15 629 418 903 0 171 91 0 6983 42 190 32 26 202 1923 589 13 539 93 0 108 2987 0 0 328 0 15 7977 208 301 0 32 1977 318 0 21 0 184 84 964 14 834 722
1998 0 899 0 16 946 457 349 2 166 105 0 7673 44 016 276 30 008 2165 463 14 115 97 49 138 2915 0 102 367 1 0 11 291 159 866 0 22 2120 295 0 30 18 178 87 449 0 839 121
1999 4 1073 272 19 266 460 169 3 192 93 0 7087 40 800 253 23 936 2437 0 14 908 66 42 102 3348 0 0 348 2 32 12 189 145 807 0 31 1654 289 0 22 0 117 88 879 0 823 421
2000 3 1043 307 18 891 463 373 1 144 59 54 7578 39 384 210 21 782 2234 449 15 057 75 34 91 3109 4 86 344 0 0 12 121 128 495 0 43 1728 303 0 24 0 152 89 792 0 806 970
2001 3 980 216 19 170 485 221 2 183 45 63 7262 35 489 189 37 268 2382 465 14 830 58 56 95 3526 3 64 377 0 0 3470 107 133 0 22 1536 292 0 11 0 173 90 679 0 811 263
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TABLE 9
Trend in notified tuberculosis cases (new smear-positives) in DOTS and non-DOTS areas
1977 881 145 41 13 373 22 6050 852 1285 182 29 57 22 917
1978 741 101 32 13 198 4 6313 903 1375 174 41 52 22 934
1979 807 114 41 12 806 21 34 633 6622 883 1197 184 28 52 57 388
1980 0 765 111 52 12 291 10 38 211 6819 5 10 967 17 275 1266 153 32 23 59 78 049
1981 6 723 97 39 12 214 34 43 868 6766 0 4 5 867 19 006 32 1062 174 18 10 34 33 243 118 202
1982 3 690 5801 19 236 98 32 12 649 17 46 735 7320 11 6 11 34 2 942 20 676 30 998 176 25 3 49 33 014 148 558
1983 6 596 5316 25 628 79 48 13 010 14 45 688 7251 3 6 32 60 6 870 18 657 25 860 130 23 7 55 32 612 150 982
1984 9 634 5507 38 367 82 52 13 277 42 561 6660 28 7 18 1061 21 291 20 992 155 25 3 55 30 426 161 230
1985 2 583 5235 53 078 99 48 4142 13 808 48 515 6682 4 8 14 363 69 4 870 39 571 949 155 23 3 51 34 217 208 493
1986 5 8715 60 949 86 49 4110 13 745 49 083 6653 5 4 10 320 66 0 606 50 624 839 101 18 5 36 30 381 226 410
1987 3 7173 75 45 4042 14 405 45 066 6924 22 18 271 55 4 839 72 150 740 115 12 7 26 34 530 186 522
1988 8246 65 44 3918 14 592 39 040 6718 276 62 1273 63 655 794 137 7 7 46 39 486 178 366
1989 5842 76 43 3768 14 710 33 968 133 6711 234 40 951 97 070 823 149 2 39 35 095 199 654
1990 5132 83 3670 15 498 30 700 124 6774 185 37 611 840 117 16 7 30 728 94 522
1991 8507 63 34 3564 15 285 28 790 526 140 6752 128 33 489 88 17 5 35 865 100 286
1992 536 12 910 90 184 4 75 40 15 540 17 736 459 158 6754 21 14 19 92 32 2 841 130 0 17 5 84 38 659 184 312
1993 1 557 68 9560 84 898 4 39 53 2429 15 210 99 16 630 765 108 6954 12 8 87 35 91 0 8 812 92 279 21 155 16 2 41 36 534 267 476
1994 11 058 104 729 1 60 38 40 14 777 184 18 375 752 171 6861 22 15 200 2 42 61 0 11 573 87 401 18 861 114 0 17 1 62 35 613 2 282 061
1995 3 0 0 11 101 134 488 0 68 0 0 0 14 367 0 11 754 726 141 6688 14 0 0 622 0 0 47 1 9 1652 94 768 0 15 455 109 1 9 6 30 37 550 0 314 624
1996 0 0 0 12 065 168 270 0 69 37 0 2116 12 867 144 11 420 886 204 7271 0 17 10 622 0 26 76 1 4 652 86 695 0 10 455 90 1 16 0 0 48 911 0 352 935
1997 6 171 0 12 686 188 529 0 66 41 0 1536 13 571 11 9957 1234 304 7596 14 0 11 1171 0 0 57 0 7 1195 83 353 0 14 432 113 0 12 0 66 53 647 1 375 801
1998 0 203 0 13 865 214 462 1 74 34 0 1869 11 935 50 10 359 1508 226 7802 26 11 28 1356 0 30 81 0 0 2107 71 663 0 7 480 140 0 16 0 38 54 873 0 393 244
1999 3 285 102 15 744 212 426 0 65 33 0 1566 12 909 59 9559 1719 0 7960 15 17 16 1513 0 0 69 1 20 1914 73 373 0 17 465 93 0 10 0 43 53 805 0 393 801
2000 2 251 84 14 822 213 766 0 62 29 42 1940 11 853 54 8 216 1526 133 8156 27 11 15 1389 4 38 74 0 0 2267 67 056 0 13 248 109 0 15 0 63 53 169 0 385 434
2001 2 228 95 14 361 212 766 2 73 24 47 1853 11 408 64 11 805 1533 157 8309 19 15 8 1631 2 34 68 0 0 462 59 341 0 12 357 118 0 8 0 56 54 202 0 379 060
Year
W
P
R
W
allis and Futuna
Viet N
am
Vanuatu
Tuvalu
Tonga
Tokelau
Solom
on Islands
S
ingapore
S
am
oa
Pitcairn Islands
P
hilippines
Papua N
ew
 G
uinea
Palau
N
iue
N
ew
 Zealand
N
ew
 C
aledonia
N
auru
M
ongolia
M
icronesia, FS
M
arshall Islands
N
. M
ariana Islands
M
alaysia
M
acao, C
hina
Lao PD
R
R
epublic of K
orea
K
iribati
Japan
H
ong K
ong, C
hina
G
uam
French Polynesia
Fiji
C
ook Islands
C
hina
C
am
bodia
B
runei D
arussalam
A
ustralia
A
m
erican Sam
oa
22
TABLE 10
Trend in tuberculosis notification rates per 100 000 population (all types)
1976 40 10 207 44 81 58 176 87 505 89 65 76 20 38 65 338 52 123 154 74 221 115
1977 23 9 43 68 82 156 78 173 80 30 71 20 50 79 238 23 119 172 68 152
1978 26 9 133 30 55 76 141 70 71 80 21 71 19 100 84 260 38 126 192 95 128 134
1979 6 11 121 167 33 55 68 161 66 162 218 83 14 70 17 64 77 234 37 117 205 75 100 163 23
1980 6 10 106 206 33 49 51 158 61 243 236 411 81 19 71 78 15 113 84 233 37 112 118 69 471 155 80
1981 18 9 148 59 28 39 37 149 56 307 254 196 78 153 22 65 90 14 67 78 236 31 99 134 52 225 77 79
1982 17 8 123 118 10 106 25 31 49 145 54 322 82 441 38 93 77 72 14 142 83 204 27 88 130 0 45 150 140 91
1983 24 8 110 107 11 161 28 40 42 138 52 208 229 150 78 435 45 100 86 111 13 100 84 204 25 83 117 48 288 134 76
1984 34 8 95 142 14 105 24 46 45 145 51 179 211 217 70 305 34 85 91 95 12 154 106 284 23 84 125 0 56 113 145 75
1985 14 7 106 137 21 180 32 47 31 137 49 163 212 146 67 320 54 73 162 69 11 217 108 276 76 140 100 49 400 95 78
1986 22 6 94 136 25 85 28 44 40 135 47 202 212 101 67 80 128 64 148 66 10 93 85 274 68 102 36 338 97 77
1987 24 6 80 117 30 94 23 37 27 130 46 169 208 94 66 136 107 103 125 48 9 271 90 279 18 62 116 450 25 275 62 86
1988 35 6 52 135 33 88 22 34 33 123 45 315 177 72 65 71 26 79 127 69 9 121 118 308 18 63 122 50 15 300 79 82
1989 14 6 99 33 5 29 32 60 116 43 178 165 60 62 74 18 72 109 69 9 25 87 362 22 60 153 29 313 90 81
1990 32 6 56 79 33 6 34 33 32 112 42 100 149 76 61 79 79 10 67 516 27 59 120 50 23 288 96 72
1991 4 6 130 33 28 27 106 41 134 45 70 60 75 84 10 50 90 330 94 19 200 156 81
1992 6 188 71 32 45 111 39 141 110 23 77 61 146 106 103 69 82 9 67 65 377 16 54 109 50 23 375 96 82 29
1993 8 6 56 143 29 32 39 49 113 38 107 41 83 63 120 151 64 85 8 50 156 135 269 29 62 104 33 311 73 74 45.7
1994 152 30 21 29 41 64 109 36 329 105 24 88 59 98 171 77 36 74 10 100 256 130 272 27 59 91 0 23 211 92 71 79 45.5
1995 11 6 0 146 29 5 26 0 0 96 34 0 74 27 80 58 66 0 0 122 0 0 9 50 112 187 347 31 57 93 50 20 360 47 76 27 48.2
1996 0 6 0 145 38 0 25 39 0 99 34 409 69 29 103 63 0 98 75 120 0 111 5 100 29 116 399 22 56 74 50 22 0 0 99 0 57.9
1997 10 6 0 149 34 0 21 40 0 106 34 40 57 37 134 64 143 0 83 116 0 0 9 0 88 177 295 19 57 79 0 21 0 103 111 100 50.8
1998 0 5 0 158 36 10 20 46 0 115 35 333 65 40 105 66 139 80 103 111 0 50 10 50 0 245 222 13 61 71 0 30 180 98 112 0 50.6
1999 6 6 85 175 36 15 23 40 0 105 32 298 51 44 0 68 89 67 74 125 0 0 9 100 178 259 198 18 47 63 0 22 0 63 112 0 49.2
2000 5 5 91 157 37 6 17 26 35 112 31 250 46 42 103 68 109 56 79 131 33 41 9 0 0 236 168 25 53 74 0 24 0 76 117 0 49.0
2001 4 5 65 143 38 10 22 19 40 104 28 225 79 44 104 66 76 108 75 138 24 29 10 0 0 71 139 14 37 63 0 11 0 86 115 0 47.7
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TABLE 11
Trend in tuberculosis notification rates per 100 000 population (smear-positives)
1976 7 21 31 12 42 53 59 94 24 69
1977 6 24 30 12 39 47 30 55 88 32 58
1978 5 17 23 11 7 48 31 58 81 44 51
1979 6 18 28 11 36 92 49 30 50 83 29 46
1980 0 5 18 35 11 17 100 50 16 67 32 36 52 68 34 329 51
1981 18 5 15 26 10 56 113 48 0 13 33 28 38 21 43 75 19 125 28 61
1982 9 5 84 2 15 21 11 28 119 50 65 19 15 23 17 29 40 19 40 70 25 38 40 59
1983 18 4 75 3 12 29 11 23 114 49 18 18 44 41 43 25 36 16 34 50 22 88 43 57
1984 26 4 76 4 12 33 11 105 44 147 20 20 32 40 12 39 58 26 38 42 52
1985 6 4 71 5 14 30 75 11 118 42 20 29 15 20 2 33 26 72 37 57 23 38 39 57
1986 14 115 6 12 27 75 11 117 41 25 14 11 17 2 0 18 90 32 35 19 63 27 49
1987 8 92 10 26 72 12 107 41 61 19 14 2 29 23 123 28 40 13 88 18 53
1988 104 9 23 69 12 93 40 14 2 35 107 30 45 7 88 31 62
1989 73 10 24 65 12 80 29 39 11 25 24 162 31 47 25 24 54
1990 63 11 63 13 72 27 38 9 23 17 31 37 16 88 47
1991 101 8 19 60 12 67 12 30 37 6 20 13 27 17 63 53
1992 3 150 8 24 10 22 12 41 10 41 36 46 29 18 4 19 1 30 39 0 17 63 55 56
1993 2 3 24 103 7 21 19 37 42 12 129 38 17 28 37 24 8 4 20 3 0 50 20 142 13 44 16 22 26 51 16.6
1994 111 9 5 8 18 27 12 239 41 16 43 35 47 15 9 18 24 2 0 69 14 132 11 31 31 0 17 11 38 49 14 17.5
1995 6 0 0 111 11 0 9 0 0 0 11 0 26 15 32 33 23 0 0 25 0 0 1 50 53 38 140 9 14 29 50 9 60 18 51 0 19.6
1996 0 0 0 117 14 0 9 17 0 32 10 180 25 18 46 35 0 30 8 25 0 14 1 50 24 15 125 6 13 23 50 16 0 0 65 0 21.7
1997 10 1 0 121 15 0 8 18 0 23 11 14 22 24 69 36 22 0 8 46 0 0 2 0 41 27 118 8 13 28 0 12 0 37 70 7 22.9
1998 0 1 0 129 17 5 9 15 0 28 9 60 22 28 51 36 37 18 21 52 0 15 2 0 0 46 99 4 14 34 0 16 0 21 70 0 23.7
1999 5 2 32 143 17 0 8 14 0 23 10 69 21 31 0 36 20 27 12 56 0 0 2 50 111 41 100 10 13 20 0 10 0 23 68 0 23.5
2000 4 1 25 123 17 0 7 13 27 29 9 64 17 29 30 37 39 18 13 58 33 18 2 0 0 44 88 8 8 27 0 15 0 32 69 0 23.4
2001 3 1 28 107 17 10 9 10 30 27 9 76 25 28 35 37 25 29 6 64 16 15 2 0 0 9 77 8 9 25 0 8 0 28 68 0 22.3
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TABLE 12
Trend in tuberculosis notification (number of all types) in DOTS and non-DOTS areas, 1998–2001
DOTS 6 424 0 16 946 336 535 2 166 105 0 0 0 276 30 008 2149 463 0 0
Non-DOTS 0 475 0 0 120 814 0 0 0 0 7673 44 016 0 0 16 0 14 115 97
DOTS 4 511 272 19 266 346 200 3 192 93 0 5831 40 800 253 23 936 2437 0 0 0
Non-DOTS 0 562 0 0 113 969 0 0 0 0 1256 0 0 0 0 0 14 908 66
DOTS 3 490 307 18 891 348 436 1 144 59 54 6011 15 397 210 0 1617 449 15 057 75
Non-DOTS 0 553 0 0 114 937 0 0 0 0 1567 23 987 0 21 782 617 0 0 0
DOTS 0 485 216 19 170 362 172 2 183 45 63 5907 17 809 189 0 1618 465 14 830 58
Non-DOTS 3 495 0 0 123 049 0 0 0 0 1355 17 680 0 37 268 764 0 0 0
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TABLE 13
Trend in tuberculosis notification (number of new smear-positives) in DOTS and non-DOTS
areas, 1998–2001
DOTS 6 116 0 13 865 191 290 1 74 34 0 0 0 50 10 359 1494 226 0 0
non-DOTS 0 87 0 0 23 172 0 0 0 0 1869 11 935 0 0 14 0 7802 26
DOTS 3 153 102 15 744 188 525 0 65 33 0 1566 12 909 59 9559 1719 0 0 0
non-DOTS 0 133 23 901 0 0 0 0 0 0 0 0 0 0 7960 15
DOTS 2 122 84 14 822 191 280 0 62 29 42 1517 4415 54 0 1526 133 8156 27
non-DOTS 0 129 0 0 22 486 0 0 0 0 423 7438 0 8216 0 0 0 0
DOTS 0 99 95 14 361 188 480 2 73 24 47 1425 5709 64 0 1533 157 8309 19
non-DOTS 2 129 0 0 24 286 0 0 0 0 428 5699 0 11 805 0 0 0 0
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839 142
0 0 2725 0 102 0 1 15 2845 18 286 0 22 0 295 0 30 0 84 599 0 496 000 59
49 138 190 0 0 367 0 0 8446 141 580 0 0 2120 0 0 0 18 178 2850 0 343 142 41
823 421
42 102 3348 0 0 0 0 32 1214 31 825 0 31 1654 289 0 22 0 86 88 426 0 566 869 69
0 0 0 0 0 348 2 0 10 975 113 982 0 0 0 0 0 0 0 31 453 0 256 552 31
806 970
34 91 3109 4 0 344 0 0 2534 96 371 0 43 590 303 0 24 0 105 89 792 0 600 545 74
0 0 0 0 86 0 0 0 9587 32 124 0 0 1138 0 0 0 0 47 0 0 206 425 26
811 263
56 95 3526 3 0 89 0 0 3470 107 133 0 22 749 292 0 11 0 121 90 679 0 629 458 78
0 0 0 0 64 288 0 0 0 0 0 0 787 0 0 0 0 52 0 0 181 805 22
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%
393 257
0 0 1213 0 30 0 0 7 418 10 292 0 7 0 140 0 16 0 0 53 147 0 282 785 72
11 28 143 0 0 81 0 0 1689 61 371 0 0 480 0 0 0 0 38 1726 0 110 472 28
393 802
17 16 1513 0 0 0 0 20 254 20 477 0 17 465 93 0 10 0 24 53 561 0 306 904 78
0 0 0 0 0 69 1 0 1660 52 896 0 0 0 0 0 0 0 19 244 0 86 898 22
385 434
11 15 1389 4 0 74 0 0 403 49 991 0 13 105 109 0 15 0 26 53 169 0 327 595 85
0 0 0 0 38 0 0 0 1864 17 065 0 0 143 0 0 0 0 37 0 0 57 839 15
379 060
15 8 1631 2 0 21 0 0 462 59 341 0 12 175 118 0 8 0 46 54 202 0 336 438 89
0 0 0 0 34 47 0 0 0 0 0 0 182 0 0 0 0 10 0 0 42 622 11
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TABLE 14
Trend in tuberculosis notification (rate for all types) in DOTS and non-DOTS areas, 1998–2001
Population x 1000 63 18 445 313 10 751 1 255 091 20 822 227 161 6671 125 920 83 46 115 5358 440 21 450
DOTS 9.5 2.3 0.0 157.6 26.8 10.0 20.2 46.3 0.0 0.0 0.0 332.5 65.1 40.1 105.2 0.0
Non-DOTS 0.0 2.6 0.0 0.0 9.6 0.0 0.0 0.0 0.0 115.0 35.0 0.0 0.0 0.3 0.0 65.8
Population x 1000 64 18 641 320 10 981 1 265 979 20 834 231 164 6729 126 187 85 46 505 5525 440 21 877
DOTS 6.3 2.7 85.0 175.4 27.3 15.0 23.0 40.3 0.0 86.7 32.3 297.6 51.5 44.1 0.0 0.0
Non-DOTS 0.0 3.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 18.7 0.0 0.0 0.0 0.0 0.0 68.1
Population x 1000 68 19 138 328 13 104 1 275 133 20 814 233 155 6860 127 096 83 46 740 5279 444 22 218
DOTS 4.4 2.6 93.5 144.2 27.3 5.1 17.7 25.3 34.8 87.6 12.1 253.3 0.0 30.6 101.1 67.8
Non-DOTS 0.0 2.9 0.0 0.0 9.0 0.0 0.0 0.0 0.0 22.8 18.9 0.0 46.6 11.7 0.0 0.0
Population x 1000 70 19 338 335 13 441 1 284 972 20 823 237 158 6961 127 335 84 47 069 5403 449 22 633
DOTS 0.0 2.5 64.5 142.6 28.2 10.1 22.2 19.0 39.8 84.9 14.0 224.9 0.0 29.9 103.7 65.5
Non-DOTS 4.3 2.6 0.0 0.0 9.6 0.0 0.0 0.0 0.0 19.5 13.9 0.0 79.2 14.1 0.0 0.0
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TABLE 15
Trend in tuberculosis notification (rate for new smear-positives) in DOTS and non-DOTS
areas, 1998–2001
Population x 1000 63 18 445 313 10 751 1 255 091 20 822 227 161 6671 125920 83 46 115 5358 440 21 450
DOTS 9.5 0.6 0.0 129.0 15.2 5.0 9.0 15.0 0.0 0.0 0.0 60.2 22.5 27.9 51.4 0.0
Non-DOTS 0.0 0.5 0.0 0.0 1.8 0.0 0.0 0.0 0.0 28.0 9.5 0.0 0.0 0.3 0.0 36.4
Population x 1000 64 18 641 320 10 981 1 265 979 20 834 231 164 6729 126187 85 46 505 5525 440 21 877
DOTS 4.7 0.8 31.9 143.4 14.9 0.0 7.8 14.3 0.0 23.3 10.2 69.4 20.6 31.1 0.0 0.0
Non-DOTS 0.0 0.7 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.4
Population x 1000 68 19 138 328 13 104 1 275 133 20 814 233 155 6860 127096 83 46 740 5279 444 22 218
DOTS 3.0 0.6 25.6 113.1 15.0 0.0 7.6 12.4 27.1 22.1 3.5 65.1 0.0 28.9 29.9 36.7
Non-DOTS 0.0 0.7 0.0 0.0 1.8 0.0 0.0 0.0 0.0 6.2 5.9 0.0 17.6 0.0 0.0 0.0
Population x 1000 70 19 338 335 13 441 1 284 972 20 823 237 158 6961 127335 84 47 069 5403 449 22 633
DOTS 0.0 0.5 28.4 106.8 14.7 10.1 8.9 10.1 29.7 20.5 4.5 76.1 0.0 28.4 35.0 36.7
Non-DOTS 2.9 0.7 0.0 0.0 1.9 0.0 0.0 0.0 0.0 6.1 4.5 0.0 25.1 0.0 0.0 0.0
19
98
A
m
er
ic
an
 S
am
oa
A
us
tr
al
ia
B
ru
ne
i 
D
ar
us
sa
la
m
C
am
bo
di
a
C
hi
na
C
oo
k 
Is
la
nd
s
Fi
ji
Fr
en
ch
 P
ol
yn
es
ia
G
ua
m
H
on
g 
K
on
g,
 C
hi
na
Ja
pa
n
K
ir
i\b
at
i
R
ep
ub
lic
 o
f 
K
or
ea
La
o 
PD
R
M
ac
ao
, 
C
hi
na
M
al
ay
si
a
19
99
20
00
20
01
T U B E R C U L O S I S  C O N T R O L  I N  T H E  W H O  W E S T E R N  P A C I F I C  R E G I O N  2 0 0 3
27
70 61 134 2624 11 206 3680 2 17 4602 72 164 0 170 3491 417 2 99 10 182 77 896 14 1 657 782
0.0 0.0 0.0 103.8 0.0 49.5 0.0 50.0 88.2 61.8 25.3 12.9 0.0 70.7 0.0 30.3 0.0 0.0 108.6 0.0 29.9
138.6 80.3 103.0 7.2 0.0 0.0 10.0 0.0 0.0 183.5 196.2 0.0 60.7 0.0 0.0 0.0 13.0 97.8 3.7 0.0 20.7
74 63 137 2680 11 210 3719 2 18 4706 73 601 0 172 3541 460 2 100 10 187 79 228 14 1 673 517
0.0 66.7 74.5 124.9 0.0 0.0 0.0 0.0 177.8 25.8 43.2 18.0 46.7 62.8 0.0 22.0 0.0 46.0 111.6 0.0 33.9
89.2 0.0 0.0 0.0 0.0 0.0 9.4 100.0 0.0 233.2 154.9 0.0 0.0 0.0 0.0 0.0 0.0 16.6 0.6 0.0 15.3
73 51 123 2533 12 215 3778 2 19 4809 75 653 0 159 4018 447 1 99 10 197 78 137 14 1 688 065
103.0 66.5 74.1 122.7 32.7 0.0 9.1 0.0 0.0 52.7 127.4 27.1 14.7 67.7 0.0 24.2 0.0 53.4 114.9 0.0 35.6
0.0 0.0 0.0 0.0 0.0 39.9 0.0 0.0 0.0 199.3 42.5 0.0 28.3 0.0 0.0 0.0 0.0 23.9 0.0 0.0 12.2
76 52 126 2559 13 220 3808 2 20 4920 77 131 0 159 4108 463 1 99 10 202 79 175 15 1 702 484
76.4 108.1 75.5 137.8 24.0 0.0 2.3 0.0 0.0 70.5 138.9 13.8 18.2 63.1 0.0 11.1 0.0 59.9 114.5 0.0 37.0
0.0 0.0 0.0 0.0 0.0 29.1 7.6 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 25.8 0.0 0.0 10.7
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70 61 134 2624 11 206 3680 2 17 4602 72 164 0 170 3491 417 2 99 10 182 77 896 14 1 657 782
0.0 0.0 0.0 46.2 0.0 14.6 0.0 0.0 41.2 9.1 14.3 4.1 0.0 33.6 0.0 16.2 0.0 0.0 68.2 0.0 17.1
37.1 18.0 20.9 5.4 0.0 0.0 2.2 0.0 0.0 36.7 85.0 0.0 13.7 0.0 0.0 0.0 0.0 20.9 2.2 0.0 6.7
74 63 137 2680 11 210 3719 2 18 4706 73 601 0 172 3541 460 2 100 10 187 79 228 14 1 673 517
0.0 27.0 11.7 56.5 0.0 0.0 0.0 0.0 111.1 5.4 27.8 9.9 13.1 20.2 0.0 10.0 0.0 12.8 67.6 0.0 18.3
20.3 0.0 0.0 0.0 0.0 0.0 1.9 50.0 0.0 35.3 71.9 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.3 0.0 5.2
73 51 123 2533 12 215 3778 2 19 4809 75 653 0 159 4018 447 1 99 10 197 78 137 14 1 688 065
37.1 21.5 12.2 54.8 32.7 0.0 2.0 0.0 0.0 8.4 66.1 8.2 2.6 24.4 0.0 15.1 0.0 13.2 68.0 0.0 19.4
0.0 0.0 0.0 0.0 0.0 17.7 0.0 0.0 0.0 38.8 22.6 0.0 3.6 0.0 0.0 0.0 0.0 18.8 0.0 0.0 3.4
76 52 126 2559 13 220 3808 2 20 4920 77 131 0 159 4108 463 1 99 10 202 79 175 15 1 702 484
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TABLE 16
Treatment outcome of new smear-positive cases registered in 2000 in DOTS areas
Not evaluated Completed Transferred Treatment
Country Registered  (% ) Cured treatment Defaulted Failed Died out success
American Samoa 0
Australia 114 5.3 19.3 54.4 1.8 0.0 7.9 11.4 73.7
Brunei Darussalam 84 0.0 41.7 21.4 3.6 0.0 16.7 16.7 63.1
Cambodia 14 775 0.0 87.8 3.5 3.9 0.3 3.6 0.8 91.4
China 191 280 1.8 94.6 0.0 0.8 1.0 1.0 0.9 94.6
Cook Islands 0
Fiji 62 0.0 80.6 4.8 8.1 0.0 4.8 1.6 85.5
French Polynesia 62 0.0 0.0 96.8 0.0 1.6 1.6 0.0 96.8
Guam 43 0.0 93.0 0.0 0.0 0.0 7.0 0.0 93.0
Hong Kong, China 1517 0.0 70.3 5.3 4.3 8.0 3.9 8.2 75.6
Japan 4984 12.7 47.2 22.5 2.0 5.5 10.0 0.0 69.7
Kiribati 54 0.0 83.3 7.4 0.0 1.9 7.4 0.0 90.7
Republic of Korea 0
Lao PDR 1392 0.0 72.8 8.7 8.5 0.4 6.8 2.8 81.5
Macao, China 160 0.0 81.3 8.1 4.4 0.0 5.6 0.6 89.4
Malaysia 0
N. Mariana Islands 27 0.0 81.5 0.0 0.0 0.0 0.0 18.5 81.5
Marshall Islands 11 0.0 63.6 27.3 9.1 0.0 0.0 0.0 90.9
Micronesia, FS 14 0.0 92.9 0.0 0.0 0.0 7.1 0.0 92.9
Mongolia 1389 0.1 83.2 3.7 4.2 3.3 2.7 2.8 86.8
Nauru 0
New Caledonia 0
New Zealand 14 50.0 21.4 28.6 0.0 0.0 0.0 0.0 50.0
Niue 0
Palau
Papua New Guinea 422 4.7 38.6 24.2 25.6 0.5 2.4 4.0 62.8
Philippines 50 196 0.1 72.6 15.2 5.8 1.2 2.3 2.8 87.8
Pitcairn Islands
Samoa 13 0.0 84.6 7.7 0.0 0.0 7.7 0.0 92.3
Singapore 105 0.0 0.0 84.8 7.6 1.0 6.7 0.0 84.8
Solomon Islands 118 0.0 66.1 26.3 6.8 0.0 0.8 0.0 92.4
Tokelau 0
Tonga 15 0.0 93.3 0.0 0.0 6.7 0.0 0.0 93.3
Tuvalu
Vanuatu 26 0.0 76.9 11.5 3.8 0.0 7.7 0.0 88.5
Viet Nam 53 169 0.1 89.9 2.2 1.8 1.0 3.1 1.9 92.1
Wallis and Futuna
Total 320 046 1.3 88.9 3.5 2.0 1.1 1.9 1.4 92.3
Outcomes of treatment (%)
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TABLE 17
Treatment outcome of new smear-positive cases registered in 2000 in non-DOTS areas
Not evaluated Completed Transferred Treatment
Country Registered  (% ) Cured treatment Defaulted Failed Died out success
American Samoa 2 0.0 0.0 100.0 0.0 0.0 0.0 0.0 100.0
Australia 124 14.5 33.9 37.1 3.2 0.0 9.7 1.6 71.0
Brunei Darussalam
Cambodia
China 22 486 2.9 81.3 0.0 4.0 7.4 1.6 2.8 81.3
Cook Islands
Fiji
French Polynesia
Guam
Hong Kong, China 423 78.3 2.4 5.0 1.4 0.0 11.1 1.9 7.3
Japan 5364 74.0 13.8 8.9 0.4 2.2 0.7 0.0 22.7
Kiribati
Republic of Korea 3231 0.8 80.9 1.6 3.1 1.3 1.6 10.7 82.5
Lao PDR 62 0.0 53.2 11.3 19.4 1.6 12.9 1.6 64.5
Macao, China
Malaysia
N. Mariana Islands
Marshall Islands
Micronesia, FS
Mongolia
Nauru 4 25.0 25.0 0.0 0.0 0.0 0.0 50.0 25.0
New Caledonia 45 0.0 33.3 55.6 2.2 0.0 8.9 0.0 88.9
New Zealand 59 74.6 1.7 23.7 0.0 0.0 0.0 0.0 25.4
Niue
Palau
Papua New Guinea 6165 0.0 0.0 67.3 14.4 5.3 3.6 9.4 67.3
Philippines
Pitcairn Islands
Samoa
Singapore 137 0.0 0.0 61.3 19.7 0.0 19.0 0.0 61.3
Solomon Islands
Tokelau
Tonga
Tuvalu
Vanuatu 37 100.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Viet Nam
Wallis and Futuna
Total 38 139 13.3 57.0 12.8 5.2 5.6 2.0 4.1 69.8
Outcomes of treatment (%)
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TABLE 18
Treatment outcome of re-treatment cases registered in 2000 in DOTS areas
Not evaluated Completed Transferred Treatment
Country Registered  (% ) Cured treatment Defaulted Failed Died out success
American Samoa
Australia 7 0.0 0.0 85.7 0 0 0 14.3 85.7
Brunei Darussalam
Cambodia 827 0.0 85.4 4.6 0 0 0 0.1 90.0
China 43 252 8.0 86.5 2.2 0 0 0 0.4 88.6
Cook Islands
Fiji
French Polynesia
Guam
Hong Kong, China 218 0.0 26.6 26.1 0 0 0 7.8 52.8
Japan 605 13.1 46.4 20.8 0 0 0 0.0 67.3
Kiribati 9 0.0 88.9 0.0 0 0 0 0.0 88.9
Republic of Korea
Lao PDR 51 0.0 51.0 9.8 0 0 0 2.0 60.8
Macao, China 37 0.0 67.6 16.2 0 0 0 0.0 83.8
Malaysia
N. Mariana Islands
Marshall Islands
Micronesia, FS 20 0.0 25.0 60.0 0 0 0 0.0 85.0
Mongolia 126 0.8 57.1 14.3 0 0 0 4.8 71.4
Nauru
New Caledonia
New Zealand 8 50.0 0.0 50.0 0 0 0 0.0 50.0
Niue
Palau
Papua New Guinea 68 2.9 29.4 35.3 0 0 0 5.9 64.7
Philippines
Pitcairn Islands
Samoa
Singapore
Solomon Islands 3 0.0 0.0 100.0 0 0 0 0.0 100.0
Tokelau
Tonga 1 0.0 100.0 0.0 0 0 0 0.0 100.0
Tuvalu
Vanuatu 5 0.0 100.0 0.0 0 0 0 0.0 100.0
Viet Nam 8806 3.5 74.0 4.7 0 0 0 3.3 78.7
Wallis and Futuna
Total 54 043 7.2 83.5 3.0 1.3 2.0 2.2 0.9 86.6
Outcomes of treatment (%)
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TABLE 19
Treatment outcome of re-treatment cases registered in 2000 in non-DOTS areas
Not evaluated Completed Transferred Treatment
Country Registered  (% ) Cured treatment Defaulted Failed Died out success
American Samoa
Australia 4 0.0 25.0 50.0 0 0 0 0.0 75.0
Brunei Darussalam
Cambodia
China
Cook Islands
Fiji
French Polynesia
Guam
Hong Kong, China 13 0.0 23.1 7.7 0 0 1 7.7 30.8
Japan 564 70.6 15.2 9.4 0 0 0 0.0 24.6
Kiribati
Republic of Korea 131 2.3 58.8 1.5 0 0 0 19.1 60.3
Lao PDR
Macao, China
Malaysia
N. Mariana Islands
Marshall Islands
Micronesia
Mongolia
Nauru
New Caledonia
New Zealand 15 73.3 0.0 20.0 0 0 0 0.0 20.0
Niue
Palau
Papua New Guinea
Philippines
Pitcairn Islands
Samoa
Singapore
Solomon Islands
Tokelau
Tonga
Tuvalu
Vanuatu 1 100.0 0.0 0.0 0 0 0 0.0 0.0
Viet Nam
Wallis and Futuna
Total 728 56.7 22.9 8.4 2.2 4.1 2.1 3.6 31.3
Outcomes of treatment (%)
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CHART 1
Notification of all cases (rate per 100 000) by country, Western
Pacific Region, 2001
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CHART 2
Notification of new smear-positive cases (rate per 100 000)
by country, Western Pacific Region, 2001
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CHART 3
Notification rate of new smear-positive cases by age and sex* in
DOTS areas, Western Pacific Region, 2001
*Population by age and sex is taken from Demographic Tables for the Western Pacific Region, 2000–2005.
CHART 4
DOTS enrolment rate* in high-burden countries, Western Pacific
Region, 2001
*Population of notified cases enroled under DOTS strategy out of all notified cases.
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CHART 5
DOTS enrolment rate* of new smear-positive cases in high-
burden countries, Western Pacific Region, 1997 and 2001
*Population of notified cases enroled under DOTS strategy out of all notified cases.
CHART 6
DOTS case detection rate of new smear-positive cases in high-
burden countries, Western Pacific Region, 2001
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CHART 7
Treatment success of new smear-positive cases under DOTS in
high-burden countries, Western Pacific Region, 2001
CHART 8
DOTS progress in high-burden countries in the Western Pacific
Region, 1998–2001
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Annex 1
Profiles of high-burden countries in the Western Pacific Region
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Seven countries in the Region have been identified as having a high burden oftuberculosis. Cambodia, China, the Philippines and Viet Nam are among the 22 globallydefined high-burden countries (based on estimated incidence); the Lao People’s
Democratic Republic, Mongolia and Papua New Guinea are defined as high-burden countries in
the regional context.
The following country profiles for the seven high-burden countries in the Western Pacific
Region have been updated using information provided during the last regional meeting of the NTP
managers in Cebu, Philippines (December 2002).
ANNEX 1
Profiles of high-burden
countries in the
Western Pacific Region
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TABLE A1
Key indicators for tuberculosis control, 1998–2001
Key Indicators 1998 2001
Total population x 1000 10 715 13 441
Notification all cases 16 946 19 170
Notification new S+ 13 865 14 361
New S+ out of all cases, % 82 75
Detection rate all cases, % 24 24
Detection rate new S+, % 54 41
Population with access to DOTS, % 100 100
DOTS enrolment rate (new S+, %) 98 98
DOTS case detection rate (new S+, %) 53 40
Treatment success under DOTS (new S+, %) 91 91
Prevalence of HIV infection among tuberculosis cases, % 5.2 (1997) 8.4 (2002)
Cambodia is ranked the 20th high burden country for tuberculosis globally and fourth in theRegion (by estimated incidence of all cases). The NTP has set up DOTS in all
77 operational districts in 145 tuberculosis units and in 381 health centres (40%) at village level, in order to monitor the continuation
phase of treatment. DOTS enrolment and treatment success rates are high. Increased case detection is expected in the coming year
following expansion of DOTS  to more operational districts. Prevalence of HIV infection among tuberculosis patients is a major concern
and has increased, from 6% in 2000 to 8.4% in 2002 (in a sentinel group of 2358 tuberculosis patients in 21 provinces, HIV/AIDS
Sentinel Surveillance 2002, NCHADS, Cambodia).
DOTS Progress DOTS started in 1994
(1) Political commitment Clear policies, guidelines and plans in line with DOTS
Regular Interagency Coordinating Committee meetings
90% of management posts filled
(2) Diagnosis by microscopy Smear microscopy available in 145 tuberculosis units
Culture and drug sensitivity testing at central level
Quality assurance at central and district level
90% of diagnostic centres provide good quality services
(3) DOT and tuberculosis drugs Available > 95% of the time
98% DOTS enrolment of new smear-positive cases
In all province and district hospitals and 40% of the health centres
(4) Monitoring Training and supervision according to plan
Reporting from all tuberculosis units
DOTS enrolment
and treatment
success rates are
high. Increased
case detection is
expected in the
coming year
following
expansion of
DOTS to more
operational
districts.
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China has the second highest tuberculosis burden globally and is ranked highest in the Region with70% of estimated all cases and 61% of all notified cases in 2001. The case detection rate for new
smear-positive cases (out of estimated cases) was 33%. About 68% of the population has access to DOTS. Treatment success was
82% for new smear-positive cases (cohort 2000 in DOTS areas). A new NTP started in 2002 in 31 provinces (after the World Bank
Health V project and Ministry of Health projects terminated in 2001). Multidrug resistance (combined resistance to at least rifampicin
and isoniazide) was found to be high in China, ranging from 2.9% to 5.3% of newly detected cases in three provinces (2000). A joint
monitoring mission in November 2002 identified several major constraints: insufficient human resources at central and provincial
levels, inadequate financial support from prefectures/counties, lack of budgeted planning, weak drugs procurement and management
capacity, and difficulty maintaining quality of DOTS in the context of rapid programme expansion and ensuring complementary funding
from different sources.
TABLE A2
Key indicators for tuberculosis control, 1998–2001
Key Indicators 1998 2001
Total population x 1000 1 255 697 1 284 972
Notification all cases 457 349 485 221
Notification new S+ 214 462 212 766
New S+ out of all cases, % 47 44
Detection rate all cases, % 32 34
Detection rate new S+, % 33 33
Population with access to DOTS, % 64 68
DOTS enrolment rate (new S+, %) 74 75
DOTS case detection rate (new S+, %) 89 89
Treatment success under DOTS (new S+, %) 30 29
Treatment success new S+, % DOTS (non-DOTS) 96 96 (81)
Primary multidrug resistant tuberculosis (new S+, %)
Guangdong — (2000) 5.3
Zhejiang 4.3
Shandong 2.9
DOTS Progress DOTS started in 1991
(1) Political commitment Tuberculosis manual and guidelines in line with DOTS
 ICC meeting
Support from CIDA, DFB, GFATM, JICA, KNCV, WB, WHO
2003 DOTS expansion plan available
(2) Diagnosis by microscopy Smear microscopy available in 31 provinces, 321 prefectures and
1857 counties (65%)
Culture available in 31 provinces, 216 prefectures and 230 counties (8%)
Drug sensitivity testing in 15 provinces and 21 prefectures
Quality assurance in all microscopy centres
Adequate quality in 70–90% of diagnosis centres
(3) DOT and tuberculosis drugs 89% DOTS enrolment of new smear-positive cases
Available > 95% of the time
(4) Monitoring Training, supervision according to plan, joint monitoring mission in five
provinces in November 2002
Reporting <80% of tuberculosis units
Multidrug
resistance
(combined
resistance to at
least rifampicin
and isoniazide)
was found to be
high in China,
ranging from 2.9%
to 5.3% of newly
detected cases in
three provinces.
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TABLE A3
Key indicators for tuberculosis control, 1998–2001
Key Indicators 1998 2001
Total population x 1000 5163 5403
Notification all cases 2165 2382
Notification new S+ 1508 1533
New S+ out of all cases, % 70 64
Detection rate all cases, % 25 19
Detection rate new S+, % 39 27
Population with access to DOTS, % 71 78
DOTS enrolment rate (new S+, %) 99 100
DOTS case detection rate (new S+, %) 39 26
Treatment success under DOTS (new S+, %) 62 82
The Lao People’s
Democratic Republic was ranked the fifth high-burden country for
 tuberculosis in the Region in 2001. DOTS had started in 16 provinces and 92 districts by the end of 2002. The two remaining
provinces (with 32 districts) will start DOTS in 2003. The case detection rate for smear-positive cases was 26% in 2001 with treatment
success reaching 82%.
DOTS is implemented in the government hospital service, from central to district hospital level, in 163 DOTS units covering 74.5%
of the population. Tuberculosis drugs are free for hospitalized patients (in government hospitals). DOTS is not extended to the private
sector (clinics and pharmacies). Full DOTS coverage is expected by the end of 2003. Also, DOTS will be decentralized in health
posts at village level in three pilot provinces.
DOTS Progress DOTS started in 1995
(1) Political commitment No ICC established, 2003 plan available
50–80% of tuberculosis staff positions filled
Tuberculosis manual and guidelines in line with DOTS strategy
(2) Diagnosis by microscopy 95% of laboratory technicians trained for tuberculosis
Culture and drug sensitivity testing not available
Quality assurance at central level and provinces in all centres by
random sampling
Adequate quality in 70–90% of diagnosis centres
(3) DOT and tuberculosis drugs Available > 95% of the time
(4) Monitoring 100% DOTS enrolment of new smear-positive cases
Training and supervision follow plans
<80% of tuberculosis  units report to the central level
Full DOTS
coverage is
expected by the
end of 2003. Also,
DOTS will be
decentralized in
health posts at
village level in
three pilot
provinces.
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Mongolia was ranked the seventh highest burden country for tuberculosis in the Region in2001. It passed WHO targets for the first time in 2001, attaining a DOTS case
detection rate of 72% and treatment success of 87% for new smear-positive cases, two years after attaining full DOTS coverage (21
aimags and eight districts) in 1999. DOTS was also extended to all prisons in 1999 (with a cure rate of 65% in 2001). Next, the
programme will be targeted towards developing mechanisms for implementing Global Fund support, increasing quality of DOTS in
rural areas (by collaborating with poverty projects and involving family doctors) and strengthening the quality of laboratory services.
TABLE A4
Key indicators for tuberculosis control, 1998–2001
Key Indicators 1998 2001
Total population x 1000 2579 2559
Notification all cases 2915 3526
Notification new S+ 1356 1631
New S+ out of all cases, % 47 46
Detection rate all cases, % 55 70
Detection rate new S+, % 57 72
Population with access to DOTS, % 97 100
DOTS enrolment rate (new S+, %) 89 100
DOTS case detection rate (new S+, %) 51 72
Treatment success under DOTS (new S+, %) 86 87
DOTS Progress DOTS started in 1995
(1) Political commitment 2003 plan available
Tuberculosis manual and guidelines in line with DOTS
Regular Inter Agency Coordination Committee meetings
Support from DANIDA extended up to 1994
Global Fund
(2) Diagnosis by microscopy Diagnosis centres are adequate
Effective quality assessment system
Adequate quality in > 90% of the diagnosis centres
(3) DOT and tuberculosis drugs Operational guidelines are available in tuberculosis manual
Drugs available 70–95% of the time
100% DOTS enrolment of new smear-positive cases
(4) Monitoring >80% of tuberculosis staff positions are filled
Training plans available and implemented
Supervision according to plan
>80% of tuberculosis units are submitting reports
Mongolia passed
WHO targets for
the first time in
2001, attaining a
DOTS case
detection rate of
72% and
treatment
success of 87%
for new smear-
positive cases.
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Papua New Guinea was ranked as having the sixthhighest burden of tuberculosis
in the Region in 2001. DOTS started in 1997 and covered eight provinces (18% of the population) by the end of 2002. In 2001, 3470
cases were notified in DOTS provinces through the tuberculosis quarterly reporting system. Also, 15 897 “on treatment” tuberculosis
cases all types (including 1122 sputum positive cases) were reported through the monthly health information system from 571 health
centres (non-DOTS provinces). Treatment success (new smear-positives, cohort 2000) was 63%.
The priorities are to strengthen programme management in the central and regional levels, expand DOTS in the 12 remaining
provinces, improve funding from provinces and districts, upgrade laboratory services (providing refresher training for
province laboratory staff, laboratory equipment and consumables, and development of quality assessment) and increase supervision
from provinces to districts and from districts to below.
TABLE A5
Key indicators for tuberculosis control, 1998–2001
Key Indicators 1998 2001
Total population x 1000 4599 4920
Notification all cases 11 291 3470
Notification new S+ 2107 462
New S+ out of all cases, % 19 13
Detection rate all cases, % 98 29
Detection rate new S+, % 41 9
Population with access to DOTS % 9 13
DOTS enrolment rate (new S+, %) 20 100
DOTS case detection rate (new S+, %) 8 8
Treatment success under DOTS (new S+, %) 93 63
Primary multidrug resistance (2000) 1
DOTS Progress DOTS started in 1997
(1) Political commitment Insufficient human resources in central unit
2003 plan available
Tuberculosis manual and guidelines in line with DOTS
ICC was funded in 2002 and taken over by the Coordination
Committee of the Global Fund
(2) Diagnosis by microscopy Inadequate laboratory services with shortage of staff in periphery
Quality assessment is not routinely carried out
70 to 90 of the evaluated centers have satisfactory quality
(3) DOT and tuberculosis drugs Operational guidelines are available in the new manual
Drugs are available 70–95% of the time
100% DOTS enrolment of new smear-positive cases
(4) Monitoring Training plan is available and implemented in phases
Supervision guidelines are not routinely used
>80% of the tuberculosis units (in DOTS provinces) report to central level
DOTS started in
1997 and covered
eight provinces
(18% of the
population) by the
end of 2002.
In 2001, 3470
cases were
notified in
DOTS
provinces.
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The Philippines was ranked as having the seventh highesttuberculosis burden globally and second in the
Region in 2001. It reported 13% of all cases notified in the Region in 2001.
DOTS started in 1996 and was rapidly expanded to cover 97% of the population. The DOTS case detection rate also rose rapidly
to 57% in 2001 (from only 10% in 1998), while the treatment success rate is 88%.
Smear microscopy is available in each rural health unit or municipality with one validation centre in each province or city.
Tuberculosis reference laboratories (national and regional) can perform culture and drug sensitivity tests. Shortages of tuberculosis
staff at the central and regional levels and training at province and hospital levels are major constraints. Delayed procurement and
distribution of tuberculosis drugs are also a recurrent problem, resulting in drug shortages and absence of buffer stock. In
municipalities, local government units may buy variable and budget-driven amounts of drugs (Category 3) for smear-negative or
extrapulmonary cases. A Public-Private Mix DOTS pilot project aims at involving the private sector in DOTS.
TABLE A6
Key indicators for tuberculosis control, 1998–2001
Key Indicators 1998 2001
Total population x 1000 72 944 77 131
Notification all cases 159 866 107 133
Notification new S+ 71 663 59 341
New S+ out of all cases, % 45 55
Detection rate all cases, % 70 46
Detection rate new S+, % 70 57
Population with access to DOTS, % 17 97
DOTS enrolment rate (new S+,  %) 14 100
DOTS case detection rate (new S+, %) 10 57
Treatment success under DOTS (new S+, %) 83 88
DOTS Progress DOTS started in 1996
(1) Political commitment Strong central NTP unit (but shortage of staff)
New Manual of Procedures diffused in line with DOTS
Funding gap < 30%
Provinces and municipalities have allocated funds for staffing
Regular ICC meeting with partners
Inadequate advocacy and promotion to increase demand
Lack of involvement of the private sector
(2) Diagnosis by microscopy Diagnosis centres adequate and well staffed
Quality assessment system is in place but the laboratory network
needs to be strengthened
(3) DOT and tuberculosis drugs Operational guidelines are available in the new Manual of Procedures
100% DOTS enrolment of new smear-positive cases
Tuberculosis drugs subject to quality criteria
Delayed procurement and delivery of drugs, available less than 70% of
the time in one year
(4) Monitoring Inadequate monitoring and supervision
>80% of the tuberculosis units submit reports but with some delay
DOTS started in
1996 and was
rapidly expanded
to cover 97% of
the population.
The DOTS case
detection rate
also rose rapidly
to 57% in 2001.
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Viet Nam was ranked 13th among the 22 highest burden countries globally (2000) andthird in the Region, with 11% of all cases in 2001. About 1% of Viet Nam’s
tuberculosis patients were infected by HIV, although in some provinces more than 5% of tuberculosis cases were due to HIV (in
2000). Major constraints are low case detection in remote areas, fast development of the private sector, rapid turnover of staff in the
context of health sector reforms, increased HIV prevalence among tuberculosis cases, and stigmatization of tuberculosis among
health staff and the general public. NTP priorities are to improve the quality of DOTS in remote areas, step up tuberculosis education
in the community, and coordinate and integrate tuberculosis control with other programmes (the HIV programme and the Expanded
Programme of Immunization).
TABLE A7
Key indicators for tuberculosis control, 1998–2001
Key Indicators 1998 2001
Total population x 1000 77 562 79 175
Notification all cases 87 449 90 679
Notification new S+ 54 873 54 202
New S+ out of all cases, % 63 60
Detection rate all cases, % 60 63
Detection rate new S+, % 83 84
Population with access to DOTS, % 96 100
DOTS enrolment rate (new S+, %) 97 100
DOTS case detection rate (new S+, %) 81 83
Treatment success under DOTS (new S+, %) 91 92
Prevalence of HIV infection among tuberculosis cases, % 1 (2000)
Primary multidrug resistance
DOTS Progress
(1) Political commitment Strong NTP central unit, 2003 implementation plan available, NTP
manual in line with DOTS, no funding gap, regular ICC meetings
(2) Diagnosis by microscopy Microscopy services available and well staffed
With effective quality assessment system, 70–90% of centres
are of adequate quality
Two National Reference Laboratories (culture, drug sensitivity
testing, training, monitoring, research), 61 province laboratories
(smear examination, culture, quality assessment, training,
supervision) and 623 district laboratories (smear examination,
quality assessment)
Quality assessment by double reading, all positive and 10% negative
(3) DOT and tuberculosis drugs  Operational guidelines are available in the tuberculosis manual
>80% of new smear-positives are under DOTS
Tuberculosis drugs available, >95% with quality assessment
(4) Monitoring Training plan and supervision guidelines are available and implemented,
>80% of reporting units submit their reports
About 1% of
Viet Nam’s
tuberculosis
patients were
infected by HIV,
although in some
provinces more
than 5% of
tuberculosis
cases were
due to HIV.
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Definitions of tuberculosis cases
A case of tuberculosis: A patient in whom tuberculosis has been bacteriologically confirmed,
or has been diagnosed by a clinician. Any person given treatment for tuberculosis should
be recorded.
All types: The sum of new smear-positive pulmonary, relapse, new smear-negative
pulmonary and extrapulmonary cases.
New smear-positive pulmonary: A patient who has never received treatment for tuberculosis
or has taken anti-tuberculosis drugs for less than four weeks and who has one of the
following:
• Two or more initial sputum smear examinations positive for acid fast bacilli (AFB); or
• one sputum examination positive for AFB plus radiographic abnormalities consistent
with active pulmonary tuberculosis as determined by a treating medical officer; or
• one sputum specimen positive for AFB and at least one sputum specimen that is culture
positive for AFB.
New smear-negative pulmonary: A case of pulmonary tuberculosis that does not meet the
above definition for smear-positive tuberculosis:
Extrapulmonary tuberculosis: Tuberculosis of organs other than the lungs: e.g. pleura, lymph
nodes, abdomen, genito-urinary tract, skin, joints and bones, meninges, etc. Diagnosis
should be based on one culture-positive specimen, or histological or strong clinical evi-
dence consistent with active extrapulmonary tuberculosis, followed by a
decision by a clinician to treat with a full course of anti-tuberculosis chemotherapy. (A patient
diagnosed with both pulmonary and extrapulmonary tuberculosis should be classified as a
case of pulmonary tuberculosis.)
Retreatment cases: Relapses, failures and defaulters.
Relapse: A patient previously treated for tuberculosis and declared cured or treatment
completed, who is later diagnosed with bacteriologically positive (culture smear) tuberculosis.
Definitions of treatment outcome
Cured: A patient who is sputum smear-negative in the last month of treatment and on at least
one previous occasion.
Completed treatment: A patient who has completed treatment but who does not meet the
criteria to be classified as a cure or a failure.
Treatment success: The sum of patients who are cured and those who have completed
treatment.
ANNEX 2
Definitions6
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Died: A patient who dies for any reason during the course of treatment.
Failure: A patient who is sputum smear-positive at five months or later during the course of
treatment.
Defaulted: A patient who has interrupted treatment for two consecutive months or more.
Transferred out: A patient who has been transferred to another recording and reporting unit
and for whom the treatment outcome is not known.
Not evaluated: Patients who did not have the treatment outcome evaluated.
Note: In countries where culture is current practice, patients can be classified as cured or a failure on the basis
of culture results.
Indicators to assess treatment outcome
Cure rate: Proportion of cured cases out of all cases registered in a certain period (in 2000 in
this report).
Treatment success rates: The sum of the proportion of patients who were cured and patients
who completed treatment out of all cases registered in a certain period. The global
target is a cure rate of 85% and a greater treatment success rate.
The cure rate and treatment success rate are expressed as a percentage of registered
cases. The number of new cases registered for treatment in 2000 (reported in 2002) is
compared to the number of cases notified as smear-positive in 2000 (reported in 2001).
Differences may arise because NTPs do not compile data at the end of each calendar
year, diagnoses may be incorrect, patients are lost between diagnosis and the start of
treatment, or records are lost. Second, only a fraction of registered cases was
evaluated for outcome. All registered cases should be evaluated. Third, data on the six
standard, mutually exclusive outcomes of treatment are compiled. These figures are
reported as percentages of all registered cases, so that the possible outcomes plus the
fraction of cases not evaluated sum to 100%. When a country states the number of patients
registered for treatment, but gives no outcomes, no result is reported rather than zero
treatment success. Although treatment outcomes are expressed as
percentages, they are referred to as rates. The six possible outcomes plus the fraction of
cases not evaluated total 100%. If the number of registered cases is lower than the sum of
the six outcomes or is missing, the denominator for treatment success will be the number
evaluated or the number of smear-positive cases notified in the previous year,
whichever is greater.
Case detection rate and DOTS detection rate
DOTS. The recommended strategy for tuberculosis control. It comprises
• government commitment to ensuring sustained, comprehensive tuberculosis control
activities;
• case detection by sputum smear microscopy among symptomatic patients self-
reporting to health services;
• standardized short-course chemotherapy using regimens of six to eight months, for at
least all confirmed smear-positive cases. Good case management includes DOT during
the intensive phase for all new sputum smear-positive cases, the continuation phase of
rifampicin-containing regimens and the whole re-treatment regimen;
• a regular, uninterrupted drug supply of all essential anti-tuberculosis drugs; and
• a standardized recording and reporting system that allows assessment of case-
finding and treatment results for each patient and of the tuberculosis control programme
performance overall.
T U B E R C U L O S I S  C O N T R O L  I N  T H E  W H O  W E S T E R N  P A C I F I C  R E G I O N  2 0 0 3
50
Targets for tuberculosis control were established by the World Health Assembly:
• to cure 85% of the sputum smear-positive tuberculosis cases detected; and
• to detect 70% of the estimated new sputum smear-positive tuberculosis cases.
Case notifications represent only a fraction of the true number of cases in a country because
the coverage by effective NTPs will be incomplete.
The estimated case detection rate is defined as:
Case detection rate (%) = Annual new smear-positive notifications (country)
Estimated annual new smear-positive incidence (country)
DOTS detection rate refers to case detection under DOTS:
DOTS detection rate (%) = Annual new smear-positive notifications under DOTS
Estimated annual new smear-positive incidence (country)
The case detection rate and DOTS detection rate are identical when a country has a 100%
DOTS enrolment rate. Updated estimated incidence for 2001 in this report was provided by
WHO, Geneva.
Population with access to DOTS: The country’s population that has access to units
implementing DOTS.
DOTS Enrolment Rate (%): This indicates a proportion of cases enroled in DOTS out of
notified cases.
DOTS enrolment rate (all types) (%) = Annual notifications of all types under DOTS
Total of annual notifications of all types
DOTS enrolment rate (New S+) (%)  = Annual notification of new S+ under DOTS
Total of annual notifications of new S+
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